Omrix Quixil Fibrin Surgical Sealant Nears UK Approval; U.S. Studies Ongoing

Omrix Biopharmaceuticals is conducting clinical trials in the U.S. and Europe for its Quixil fibrin-based surgical sealant and anticipates FDA biologic license approval sometime in 2000, the firm reports.